A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Adult Japanese Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps

Clinical trial NCT07484230 · WITHDRAWN

Trial details

NCT number: NCT07484230
Sponsor: Sanofi
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Rhinosinusitis With Nasal Polyps

Start date: 2026-05-08
Primary completion: 2027-10-20
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.